Mario Leypold

Mario Leypold is an accomplished Associate Principal Scientist in Synthetic and Medicinal Chemistry at AstraZeneca, with a focus on leading Medicinal Chemistry efforts in the "Early Respiratory & Immunology" projects since October 2019. Previous roles include Senior Scientist at AstraZeneca, where contributions involved delivering lead compounds for respiratory diseases, and multiple postdoctoral positions at prestigious institutions including the Massachusetts Institute of Technology and Technische Universität Graz. Mario Leypold holds a PhD in Technical Chemistry from Technische Universität Graz and has developed expertise in synthetic protocols, metal-free functional group activation, and innovative methods in organic synthesis throughout a career that spans over a decade in the field.